Pharmacogenomics and adverse drug reactions: Primetime and not ready for primetime tests David A. Khan, MD Journal of Allergy and Clinical Immunology Volume 138, Issue 4, Pages 943-955 (October 2016) DOI: 10.1016/j.jaci.2016.08.002 Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 1 Application of pharmacogenomics to drug hypersensitivity and influence of ethnicity on genotype-associated risk. Journal of Allergy and Clinical Immunology 2016 138, 943-955DOI: (10.1016/j.jaci.2016.08.002) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 2 Timeline of important pharmacogenetic discoveries and technologies used. Journal of Allergy and Clinical Immunology 2016 138, 943-955DOI: (10.1016/j.jaci.2016.08.002) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions
Fig 3 Risk of carbamazepine-induced severe cutaneous reactions varies by genotype, phenotype and ethnicity. Journal of Allergy and Clinical Immunology 2016 138, 943-955DOI: (10.1016/j.jaci.2016.08.002) Copyright © 2016 American Academy of Allergy, Asthma & Immunology Terms and Conditions